2026 is about building with intention.
Less noise.
More depth.
More learning.
More real contribution.
I’m here to study systems, understand people, and grow by doing the work daily.
No rush. No shortcuts.
Just consistency and clarity.
#Consistency#LongTermThinking
A common misconception in RWA:
❌ Tokenizing an asset doesn't make it liquid.
You still need:
• Price discovery mechanisms
• Settlement infrastructure
• Active market participants
PicWe builds all three.
Tokenization is step 1.
Real liquidity is what we deliver.
Because of the hatred of the cockroach, the mosquitoes voted for the insecticide but when it came, it k!lled both the cockroach and the mosquitoes including the fly that never voted. 🗳️
Let's be honest.
Traditional capital markets weren't built for you:
❌Geographic barriers block global access
❌High minimums exclude retail investors
❌Illiquidity traps your capital
❌Opaque pricing hides the truth
PicWe was built to fix all four.
Real-world assets. On-chain. For everyone.
Post-Token Launch Roadmap 🗺️for @Ibonova_IPNFT on @BioProtocol and @BioProtocolEco
Mission: Deploy funds from the $IBNFT token launch to prove our Molecule-tokenized IP, synthesize a safe synthetic ibogaine derivative (from natural product origins), and deliver it directly on Bio’s product page — all governed by @SpectruthDAO.
1⃣Phase 1: IP Proving & Capital Activation (Months 1–3)
🔸Deploy launch proceeds immediately into full IP validation and strengthening on @molecule_sci.
🔸Complete on-chain proof-of-concept, data audits, and Stanford-backed 88% PTSD remission dataset integration.
🔸Activate community governance via @SpectruthDAO for milestone voting.
2⃣Phase 2: Synthesis & Derivative Development (Months 3–6)
🔸Execute lab synthesis of ibogaine and finalize the proprietary synthetic derivative (magnesium-protected, standardized, zero plant variability).
🔸Optimize for cardiac safety, precise dosing, and personalized protocols powered by Spectra/Nightingale agentic AI.
🔸Run initial wet-lab validation and epigenetic tracking pipelines.
3⃣Phase 3: Product Launch & Bio Ecosystem Integration (Months 6–9)
🔸List the finished synthetic ibogaine derivative on Bio Protocol’s product page for community access, licensing, and decentralized R&D.
🔸Enable patient-owned data flows and transparent governance through the Bio stack.
🔸Open first community-access batches and real-world outcome tracking.
4⃣Phase 4: Scale & Impact (Month 9+)
🔸Expand via @SpectruthDAO-holder proposals: additional clinics (Eastern Europe focus), regulatory fast-track support, and AI-driven personalization upgrades.
🔸Drive global PTSD/TBI relief at scale while maintaining full on-chain transparency and community ownership.
This is the accelerated, product-first DeSci path — from tokenized IP to synthetic therapy in patients’ hands.
Ready to ship. Healing has no borders. 🔥🧬
TON is still one of my favorite chains.
Market conditions shifted a lot of activity to Solana (especially memes), but I’d love to see TON reach that level again.
Do you think these upgrades can revive TON? 🚀
Pavel Durov shared an update on TON 👇
Major improvements just dropped:
• Speed now at least 10x faster
• Block rate increased 6x
• Transactions are now near instant
This is step 1 of a 7 step plan called Make TON Great Again (MTONGA)
Next step? Even lower fees.
Durov says fees will be reduced by another 6x even though TON is already cheap.
Strong push on performance + cost efficiency